This paper compared detection of EGFR mutations in case-matched plasma obtained by single- step versus two-step centrifugation protocols from patients with non-small cell lung cancer. In cases with discrepant results, the mutations were compared to results obtained using a formalin-fixed paraffin-embedded (FFPE) biopsy specimen.
Effects of Different Centrifugation Protocols on the Detection of EGFR Mutations in Plasma Cell-Free DNA.
Shin KH, Lee SM, Park K, Choi H, Kim IS, Yoon SH, Oh SH
Purpose
Conclusion
EGFR mutations were detected in 37.6% (44 of 117) and 40.2% (47 of 117) of plasma specimens centrifuged once and twice, respectively. Concordance between plasma specimens centrifuged once and twice was 89.7% (105 of 117), with 5 and 7 additional mutations detected in plasma centrifuged once and twice, respectively. Of the 12 specimens with discordant results, nine two-step centrifugation and three one-step centrifugation specimens matched results of the FFPE biopsy specimen. Importantly, 10 of the 12 discordant specimens had a semi-quantitative index (SQI) close to the limit of detection. For the mutations detected in both specimens, the semi-quantitative index (SQI) was very strongly correlated (r=0.929, P<0.0001), but the median SQI differed by mutation type in both groups (P=0.002 for 1-step and P<0.001 in 2-step centrifugation).
Studies (1)
Purpose
This study compared detection of EGFR mutations in case-matched plasma obtained by single step versus two step centrifugation protocols from patients with non-small cell lung cancer. In cases with discrepant results, the mutations were compared to results obtained using a FFPE biopsy specimen. A total of 117 blood specimens were collected using a 21-gauge needle from 110 patients (43 men, 67 women aged 35-83 years) with advanced non-small cell lung cancer into Streck BCT tubes. Within four hours of collection, blood was centrifuged at 1670 g for 10 min and frozen at -70°C for 1 week -1.5 years. DNA was then extracted directly or after a second centrifugation at 13,200 g for 10 min using the Cobas cfDNA sample preparation kit. EGFR mutations were detected using the real-time PCR-based EGFR Mutation Test v2 on a Cobas z 480 analyzer. For cases with discrepant results, DNA was extracted from 4 µm sections of FFPE biopsy specimen containing regions of tumor that was obtained between 73 days prior to blood draw to 1 day after blood draw using the PNAClamp EGFR Mutation Detection Kit or PANAMutyper (PANAGENE).
Summary of Findings
EGFR mutations were detected in 37.6% (44 of 117) and 40.2% (47 of 117) specimens centrifuged once and twice, respectively. Concordance between plasma specimens centrifuged once and twice was 89.7% (105 of 117), with 5 and 7 additional mutations detected in plasma centrifuged once and twice, respectively. Of the 12 specimens with discordant results, nine two-step centrifugation and three one-step centrifugation specimens matched results of the FFPE biopsy specimen. Importantly, 10 of the 12 discordant specimens had a semi- quantitative index (SQI) close to the limit of detection. For the mutations detected in both specimens, the semi-quantitative index (SQI) was strongly correlated (r=0.929, P<0.0001), but the median SQI differed by mutation type in both groups (P=0.002 for 1-step and P<0.001 in 2-step).
Biospecimens
FluidPlasmaTissueLungPreservation Types
FrozenFormalinDiagnoses
NeoplasticCarcinomaPlatforms
DNAReal-time qPCRPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Biospecimen location PlasmaTumor biopsyBiospecimen Aliquots and Components Centrifugation Different number of centrifugation steps compared